Efficacy and Safety of Upadacitinib in Patients from China, Brazil, and South Korea with Rheumatoid Arthritis Who Have Had Inadequate Response to Conventional Synthetic Disease-modifying Antirheumatic Drugs

被引：0

作者：

Zeng, Xiaofeng ^{[1
]}

Zhao, Dongbao ^{[2
]}

Radominski, Sebastiao ^{[3
]}

Keiserman, Mauro ^{[4
]}

Lee, Chang Keun ^{[5
]}

Meerwein, Sebastian ^{[6
]}

Enejosa, Jeffrey ^{[7
]}

Sui, Yunxia ^{[7
]}

Mohamed, Mohamed-Eslam ^{[7
]}

Park, Won ^{[8
]}

机构：

[1] Chinese Acad Med Sci, Dept Rheumatol, Peking Union Med Coll Hosp PUMCH, Natl Clin Res Ctr Dermatol & Immunol Dis NCRC DID, Beijing, Peoples R China

[2] Shanghai Changhai Hosp, Shanghai, Peoples R China

[3] Univ Fed Parana, Curitiba, Parana, Brazil

[4] Pontificial Catholic Univ, Porto Alegre, RS, Brazil

[5] Asan Med Ctr, Seoul, South Korea

[6] AbbVie Deutschland GmbH & Co KG, Pharmaceut Dev, Ludwigshafen, Germany

[7] AbbVie Inc, N Chicago, IL USA

[8] Inha Univ, Incheon, South Korea

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0211

引用

页数：2

共 50 条

[1] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS FROM CHINA, BRAZIL, AND SOUTH KOREA WITH RHEUMATOID ARTHRITIS WHO HAVE HAD INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
Zeng, X.
Zhao, D.
Radominski, S.
Keiserman, M.
Lee, C. K.
Meerwein, S.
Enejosa, J.
Sui, Y.
Mohamed, M. E.
Park, W.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1016 - 1017
[2] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS FROM CHINA BRAZIL, AND SOUTH KOREA WITH RHEUMATOID ARTHRITIS WHO HAVE HAD INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING NTIRHEUMATIC DRUGS
Zeng, Xiaofeng
Zhao, Dong-Boa
Radominski, Sebastian
Keiserman, Mriuro
Lee, Chang Keun
Meerwein, Sebastian
Enejosa, Jeffery
Sui, Yunxia
Mohamed, Mohamed-Eslam
Park, Won
[J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 98 - 99
[3] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS FROM CHINA, BRAZIL, AND SOUTH KOREA WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: RESULTS AT 64 WEEKS
Zeng, X.
Zhao, D.
Radominski, S.
Keiserman, M.
Lee, C. K.
Martin, N.
Meerwein, S.
Sui, Y.
Park, W.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1156 - 1157
[4] Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)
Burmester, Gerd R.
van den Bosch, Filip
Tesser, John
Shmagel, Anna
Liu, Yanxi
Khan, Nasser
Camp, Heidi S.
Kivitz, Alan
[J]. JOURNAL OF RHEUMATOLOGY, 2024, 51 (07) : 663 - 672
[5] EFFICACY AND SAFETY OF UPADACITINIB IN A CHINESE SUBGROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
Zeng, X.
Liu, Y.
Hu, J.
Li, J.
Wang, Y.
Zhao, D.
Wu, L.
Xiao, Z.
Li, Z.
Xu, J.
Meerwein, S.
Xie, Y.
Liang, P.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1324 - 1324
[6] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS FROM CHINA, BRAZIL, AND SOUTH KOREA WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE -MODIFYING ANTIRHEUNLVEIC DRUGS: RESULTS NE 64 WEEKS
Zeng, Xiaofeng
Zhao, Dongbao
Radominski, Sebastiao
Keiserman, Mauro
Lee, Chang K.
Martin, Naomi
Meerwein, Sebastian
Sui, Yunxia
Park, Won
[J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S104 - S104
[7] Upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional therapy
Zeng, Xiaofeng
Zhao, Dongbao
Radominski, Sebastiao C.
Keiserman, Mauro
Lee, Chang K.
Meerwein, Sebastian
Enejosa, Jeffrey
Sui, Yunxia
Mohamed, Mohamed-Eslam F.
Park, Won
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (12) : 1530 - 1539
[8] Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs
Charles-Schoeman, Christina
Burmester, Gerd
Nash, Peter
Zerbini, Cristiano A. F.
Soma, Koshika
Kwok, Kenneth
Hendrikx, Thijs
Bananis, Eustratios
Fleischmann, Roy
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (07) : 1293 - 1301
[9] Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
Choy, Ernest
Freemantle, Nick
Proudfoot, Clare
Chen, Chieh-I
Pollissard, Laurence
Kuznik, Andreas
van Hoogstraten, Hubert
Mangan, Erin
Carita, Paulo
Thi-Minh-Thao Huynh
[J]. ADVANCES IN THERAPY, 2019, 36 (04) : 817 - 827
[10] Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
Ernest Choy
Nick Freemantle
Clare Proudfoot
Chieh-I Chen
Laurence Pollissard
Andreas Kuznik
Hubert van Hoogstraten
Erin Mangan
Paulo Carita
Thi-Minh-Thao Huynh
[J]. Advances in Therapy, 2019, 36 : 817 - 827

← 1 2 3 4 5 →